These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3878608)
21. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor. Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688 [TBL] [Abstract][Full Text] [Related]
22. Determinants of von Willebrand factor activity elicited by ristocetin and botrocetin: studies on a human von Willebrand factor-binding antibody. Brinkhous KM; Fricke WA; Read MS Semin Thromb Hemost; 1985 Oct; 11(4):337-41. PubMed ID: 2416059 [TBL] [Abstract][Full Text] [Related]
23. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets. Kao KJ; Pizzo SV; McKee PA J Clin Invest; 1979 Apr; 63(4):656-64. PubMed ID: 108291 [TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. Danton MC; Zaleski A; Nichols WL; Olson JD J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492 [TBL] [Abstract][Full Text] [Related]
25. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation. Shen MC; Lin JS; Lin DS; Hsu SC; Lin B Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of ristocetin-induced platelet agglutination by vancomycin. Moake JL; Cimo PL; Peterson DM; Roper P; Natelson EA Blood; 1977 Sep; 50(3):397-406. PubMed ID: 301760 [TBL] [Abstract][Full Text] [Related]
27. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall]. Meyer D Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879 [TBL] [Abstract][Full Text] [Related]
28. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor. Turecek PL; Siekmann J; Schwarz HP Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238 [TBL] [Abstract][Full Text] [Related]
29. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations. de Romeuf C; Hilbert L; Mazurier C Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349 [TBL] [Abstract][Full Text] [Related]
30. Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease. Murata M; Fukuyama M; Satoh K; Fujimura Y; Yoshioka A; Takahashi H; Handa M; Kawai Y; Watanabe K; Ikeda Y J Clin Invest; 1993 Sep; 92(3):1555-8. PubMed ID: 8376606 [TBL] [Abstract][Full Text] [Related]
31. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells. Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402 [TBL] [Abstract][Full Text] [Related]
32. A two-site, monoclonal antibody-based immunoassay for von Willebrand factor--demonstration that vWF function resides in a conformational epitope. Chand S; McCraw A; Hutton R; Tuddenham EG; Goodall AH Thromb Haemost; 1986 Jun; 55(3):318-24. PubMed ID: 2428124 [TBL] [Abstract][Full Text] [Related]
33. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin. Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011 [TBL] [Abstract][Full Text] [Related]
34. A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor. Vanhoorelbeke K; Cauwenberghs N; Vauterin S; Schlammadinger A; Mazurier C; Deckmyn H Thromb Haemost; 2000 Jan; 83(1):107-13. PubMed ID: 10669163 [TBL] [Abstract][Full Text] [Related]
35. [Ristocetin induced platelet aggregation in children with nephrotic syndrome]. Taira K; Okajima C; Yamashita T; Kawahara S; Matsunaga T; Nakajima M; Kamitsuji H Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):659-66. PubMed ID: 2214316 [TBL] [Abstract][Full Text] [Related]
36. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma. Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346 [TBL] [Abstract][Full Text] [Related]
37. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles. Furlan M; Perret BA; Beck EA Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216 [TBL] [Abstract][Full Text] [Related]
38. Effect of platelet activation on the agglutination of platelets by von Willebrand factor. Mills DC; Hunchak K; Karl DW; Kirby EP Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674 [TBL] [Abstract][Full Text] [Related]